PB1885: PHASE 1 STUDY OF ZIFTOMENIB IN COMBINATION WITH VENETOCLAX, VENETOCLAX/AZACITIDINE, OR STANDARD INDUCTION (7 + 3) CHEMOTHERAPY IN PATIENTS WITH ACUTE MYELOID LEUKEMIA

por Zeidan, Amer M, Fathi, Amir, Issa, Ghayas, Erba, Harry, Mackey, Julie Ahsan, Corum, Daniel, Tomkinson, Blake, Kozlek, Tom, Leoni, Mollie, Wang, Eunice
Publicado 2023

PB1761: PRECLINICAL EVALUATION OF THE MENIN INHIBITOR ZIFTOMENIB IN PRIMARY AML SPECIMENS

por Stevens, Brett, Engel, Krysta, Gillen, Austin, Pei, Shanshan, Krug, Anna, Ransom, Monica, Staggs, Sarah, Burrows, Francis, Tomkinson, Blake, Kessler, Linda, Jordan, Craig, Smith, Clayton
Publicado 2023

ATX-MS-1467 Induces Long-Term Tolerance to Myelin Basic Protein in (DR2 × Ob1)F1 Mice by Induction of IL-10-Secreting iTregs

por De Souza, Adriano Luís Soares, Rudin, Stefan, Chang, Rui, Mitchell, Keith, Crandall, Timothy, Huang, Shuning, Choi, Ji-Kyung, Okitsu, Shinji L., Graham, Danielle L., Tomkinson, Blake, Dellovade, Tammy
Publicado 2018